Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment

BACKGROUND: Since 2004, the US Food and Drug Administration’s (USFDA) dedicated drug review process in support of President’s Emergency Plan for AIDS Relief (PEPFAR) has made safe, effective and quality antiretrovirals (ARVs) available for millions of patients. Furthermore, the WHO and Global Fund t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Glob Health
Hlavní autoři: Chahal, Harinder Singh, Capella, Peter, Presto, Ryan, Murray, Jeffrey S, Shimer, Martin, Valdez, Mary Lou, Lurie, Peter G
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5969730/
https://ncbi.nlm.nih.gov/pubmed/29862054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgh-2017-000651
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky